Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions Download search results Subscribe to news feed Your filters: cql: author="Skerrett-Byrne, D. A." or (type any "bookEditor journalEditor issueEditor" and editor="Sk... Add to list Miscellaneous open access Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia (vol 32, pg 788, 2018) S. Degryse, C. E. de Bock, S. Demeyer, I. Govaerts, S. Bornschein, D. Verbeke, K. Jacobs, S. Binos, D. A. Skerrett-Byrne, H. C. Murray, et al. (2018) LEUKEMIA. 32(12). p.2731-2731 Add to list Journal Article A1 open access Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia S. Degryse, C. E. de Bock, S. Demeyer, I. Govaerts, S. Bornschein, D. Verbeke, K. Jacobs, S. Binos, D. A. Skerrett-Byrne, H. C. Murray, et al. (2018) LEUKEMIA. 32(3). p.788-800